New York Rangers forward Vincent Trocheck recently opened up about the scary health issue that kept him out for a month early in the 2025-26 season. What was initially reported as an upper-body injury turned out to be a viral bacterial infection in one of his lungs. The ordeal began during a game against the Buffalo Sabres on October 9, 2025, and required surgery and hospitalization.[1][2]
Trocheck described the situation as terrifying, saying he “thought I was dying.” His revelation came during the team’s locker cleanout on April 17, 2026, shedding light on one of the key factors in the Rangers’ challenging season.

How the infection started and escalated
Trocheck first felt symptoms resembling back spasms before the infection took hold. During the October 9 matchup in Buffalo, he took a cross-check to the affected area. “Whatever fluid was in there, it’s like bubbles, and I guess the bubble burst and it spread,” Trocheck explained. The impact worsened the condition dramatically.[1]
Doctors discovered a significant buildup of fluid around his lung. He underwent surgery to drain it, involving chest tubes. Trocheck spent about a week in the hospital recovering from the procedure. The infection, described variably as viral bacteria or bacterial, spread rapidly after the on-ice hit.
The timing couldn’t have been worse, hitting just as the Rangers were finding their rhythm. Trocheck had logged an assist in that game before exiting early with 13:10 left in the second period. He missed the next 13 or 14 games, placed on long-term injured reserve on October 15.[3]
Throughout his absence, the Rangers kept details vague, calling it an upper-body injury. This secrecy fueled speculation among fans and media. Trocheck’s update finally provided clarity on the ordeal.
Recovery involved careful monitoring to prevent complications. He returned to practice gradually and made his comeback on November 10 against the Nashville Predators at Madison Square Garden.[4]
Impact on the Rangers’ season
Trocheck’s absence was a major blow to the Rangers’ lineup. As a key center and penalty-killer, his leadership and two-way play are vital. Coach Mike Sullivan acknowledged the hit: “It didn’t help. Every team has to endure injuries… Troch is obviously a really good player, an important element of this team.”[1]
The Rangers struggled early, with the season “going off the rails” partly due to this and other issues. They posted sluggish performances, including a loss to the Predators where the team “looked f---ing dead,” as Trocheck later put it.[5]
Without Trocheck, the center depth was tested. Rookies and call-ups filled gaps, but the team lacked his faceoff prowess and defensive reliability. The early-season skid contributed to a re-tooling approach by the deadline.
Sullivan noted that some injuries are tougher than others, especially key ones at critical times. Trocheck’s month out overlapped with other ailments, compounding problems. The Rangers’ playoff hopes faded amid the turmoil.
Fans watched anxiously as updates remained scarce. Trocheck’s eventual return stabilized the group, but the damage lingered through inconsistent results.
Strong return and Olympic heroics
Trocheck wasted no time upon returning on November 10. He played 65 of the remaining 66 games, showcasing resilience. His only other absence was a healthy scratch before the March trade deadline.[1]
During the NHL’s Olympic break, Trocheck represented Team USA at the 2026 Milano Cortina Games. He helped secure gold, adding international acclaim to his resume. This came despite the earlier health scare.
Stats reflected his impact: steady production in goals, assists, and hits. Trocheck’s return coincided with Gabe Perreault’s first NHL goal in a win, boosting morale.[6]
At 32, nearing 33, he remains a Rangers staple since signing in 2022. His versatility on faceoffs (career over 50%) and power play anchors the middle six.
The season’s end brought reflection. Trocheck’s endurance highlighted his value amid trade whispers.
Trade rumors and offseason outlook
With the Rangers re-tooling, Trocheck was shopped at the deadline but stayed. He was sat out as a precaution but affirmed his readiness. “I know what this is like. It doesn’t bother me,” he said of potential moves.[1]
Now, with summer ahead, he welcomes planning time if traded. His no-trade list reportedly excludes West Coast teams, per NHL Insight reports.
For more on his deadline saga, check the full ESPN story.
Trocheck eyes next season with focus, prepared for any scenario.
Other Rangers injury updates
The Rangers dealt with multiple setbacks. Matt Rempe, the physical forward, had a second surgery on his left thumb in February. He missed time since but expects to be ready for September camp. “I’m just going to come back with a vengeance,” Rempe said.
Swedish big man Adam Edstrom fractured his ankle but played through it for nearly six weeks. He and doctors opted for December surgery to protect his career. Edstrom’s toughness mirrors the team’s grit.
These injuries piled on, testing depth. Here’s a quick rundown:
- Vincent Trocheck: Lung infection/surgery, missed ~14 games (Oct 9-Nov 10).
- Matt Rempe: Thumb surgeries, out since Feb.
- Adam Edstrom: Ankle fracture/surgery, mid-season absence.
Recovery stories like these underscore NHL durability demands.
Trocheck’s candor about his scare humanizes the pros’ battles.
Vincent Trocheck’s revelation reframes the Rangers’ tough year, highlighting unseen struggles behind the stats. His comeback and Olympic gold exemplify perseverance, setting a tone for offseason resets.
As the Rangers regroup, Trocheck’s mindset—“I’ve played 13 years, I know the feeling”—signals stability. Watch for his role in potential roster shifts; his health scare only amplifies his importance.[7]
Frequently Asked Questions
Par Mike Jonderson
Mike Jonderson is a passionate hockey analyst and expert in advanced NHL statistics. A former college player and mathematics graduate, he combines his understanding of the game with technical expertise to develop innovative predictive models and contribute to the evolution of modern hockey analytics.